Abbas, Alkadar S.
HRN: 22-86-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/14/2023
04/20/2023
IV DRIP
200 Mg
Q6hrs
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes